Skip to main content

REVIEW article

Front. Med.
Sec. Nephrology
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1494740
This article is part of the Research Topic Dietary Management in Kidney Diseases: Strategies and Considerations View all articles

Renal Health Benefits and Therapeutic Effects of Parsley (Petroselinum crispum): A Review

Provisionally accepted
  • Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia

The final, formatted version of the article will be published soon.

    Parsley (Petroselinum crispum) has been used in traditional medicine for its diverse health benefits, and recent research highlights its potential in promoting renal health due to its bioactive compounds. This review focuses on evaluating the renal health benefits and therapeutic effects of parsley, addressing the growing interest in natural interventions for kidney-related conditions. It aims to consolidate existing evidence while identifying research gaps to support parsley's integration into renal health management. A systematic review of scientific databases was conducted, identifying relevant studies on parsley's biochemical properties, including flavonoids, phenolic acids, terpenoids, and essential oils, which contribute to antioxidant, antiinflammatory, diuretic, and nephroprotective effects. Animal studies demonstrated reductions in oxidative stress, improvements in metabolic biomarkers, and enhanced renal function, while limited human studies revealed modest improvements in urinary composition and renal health markers. However, parsley's safety profile, particularly at high doses, requires further investigation, including potential herb-drug interactions and safety during pregnancy. This review highlights parsley's therapeutic potential as a natural agent for renal health and underscores the need for robust clinical trials, longterm safety evaluations, and standardized methodologies to validate its clinical significance.

    Keywords: Parsley, Petroselinum crispum, Renal Health, Nephroprotection, antioxidant, antiinflammatory, diuretic, clinical trials

    Received: 11 Sep 2024; Accepted: 29 Nov 2024.

    Copyright: © 2024 Alobaidi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Sami Alobaidi, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.